Edwards Lifesciences (NYSE:EW) said it plans to buy back another $750 million worth of its own stock during the 2nd quarter, with CEO Michael Mussallem buying another $5 million worth on his own.
Wall Street Beat
Theragenics soars on private equity buyout offer
Theragenics (NYSE:TGX) said a private equity firm, Juniper Investment Co., offered to pay up to roughly $71 million for the medical device company, sending its shares to a 52-week high today on Wall Street.
Orthofix International gets pounded on The Street following rough Q1
Orthofix International (NSDQ:OFIX) shares took a pounding on Wall Street last week, after the company reported dissapointing Q1 earnings results.
Boston Scientific may finally be on the right path again
Hansen Medical sinks after missing expectations for Q1
California medical device maker Hansen Medical (NSDQ:HNSN) posted a tough 1st quarter, sending shares down 11% in afternoon trading yesterday.
The robotic surgery devices maker posted $17.2 million in losses, or 26¢ per share, on $3 million in sales during the 3 months ended March 31, 2013.
Intuitive Surgical warns on da Vinci scissor crack risk
Intuitive Surgical (NSDQ:ISRG) warned hospitals of the risk of "micro-cracks" in some of the curved scissors used with its da Vinci surgical robot that could cause internal burns.
Medtronic’s Ishrak: Europe slow to adopt renal denervation | Wall Street Beat
Boston Scientific hits 52-week high on Watchman trial results
"Bet BSX wishes that they had skipped ACC2013," wrote 1 wag today at the Heart Rhythm Society’s annual meeting, after Boston Scientific presented clinical trial results showing that its Watchman device is safer and more effective than the anticoagulant drug Warfarin.
The news sent BSX shares to $8.25 apiece today, up 10.9% over yesterday’s $7.44-per-share close, representing a new 52-week high for the stock. Shares were trading at $8.23 as of about 3:25 p.m., up 5.1% for the day.
ICU Medical surges to all-time high on rumors of $1B buyout
Shares of ICU Medical (NSDQ:ICUI) surged to an all-time high yesterday on rumors that the medical device company is mulling a $1 billion buyout.
San Clemente, Calif.-based ICU Medical hired JPMorgan Chase & Co. to help it field offers, "people familiar with the matter" told Bloomberg.
InVivo Therapeutics gains on Q1 results
Shares of InVivo Therapeutics (OTC:NVIV) area up today despite wider 1st-quarter operating losses, as investors react to news that the medical device company will seek a listing on either the New York Stock Exchange or the NASDAQ exchange.